O. M. V. Schofield

1.6k total citations
36 papers, 987 citations indexed

About

O. M. V. Schofield is a scholar working on Cell Biology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, O. M. V. Schofield has authored 36 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cell Biology, 10 papers in Pathology and Forensic Medicine and 10 papers in Dermatology. Recurrent topics in O. M. V. Schofield's work include Skin and Cellular Biology Research (19 papers), Autoimmune Bullous Skin Diseases (10 papers) and Dermatological and Skeletal Disorders (9 papers). O. M. V. Schofield is often cited by papers focused on Skin and Cellular Biology Research (19 papers), Autoimmune Bullous Skin Diseases (10 papers) and Dermatological and Skeletal Disorders (9 papers). O. M. V. Schofield collaborates with scholars based in United Kingdom, Thailand and United States. O. M. V. Schofield's co-authors include Robin A.J. Eady, John A. McGrath, B.J. Mayou, Patrick Verrando, P.G. NORRIS, R.D.R. Camp, Phillip H. McKee, Jonathan L. Rees, Adrian Heagerty and L. Thomas and has published in prestigious journals such as The Lancet, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

O. M. V. Schofield

34 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. M. V. Schofield United Kingdom 16 497 346 307 306 165 36 987
T Kobayasi Denmark 18 313 0.6× 80 0.2× 151 0.5× 154 0.5× 144 0.9× 79 901
Fabienne Jaunin Switzerland 15 214 0.4× 93 0.3× 171 0.6× 378 1.2× 160 1.0× 17 967
Jean‐Louis Bonafé France 8 437 0.9× 138 0.4× 299 1.0× 76 0.2× 298 1.8× 9 892
Anna E. Martinez United Kingdom 19 695 1.4× 83 0.2× 139 0.5× 409 1.3× 231 1.4× 62 1.0k
Leila Youssefian United States 19 504 1.0× 79 0.2× 82 0.3× 205 0.7× 521 3.2× 79 1.1k
Richard M. Haber Canada 15 244 0.5× 33 0.1× 286 0.9× 161 0.5× 191 1.2× 63 806
Elżbieta Kowalska-Olędzka Poland 11 114 0.2× 69 0.2× 473 1.5× 164 0.5× 56 0.3× 20 847
Vesarat Wessagowit United Kingdom 15 230 0.5× 66 0.2× 102 0.3× 116 0.4× 191 1.2× 31 660
Joanna Czuwara Poland 20 88 0.2× 61 0.2× 474 1.5× 332 1.1× 143 0.9× 86 1.0k
Andrew P. South United Kingdom 11 205 0.4× 55 0.2× 82 0.3× 69 0.2× 231 1.4× 13 604

Countries citing papers authored by O. M. V. Schofield

Since Specialization
Citations

This map shows the geographic impact of O. M. V. Schofield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. M. V. Schofield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. M. V. Schofield more than expected).

Fields of papers citing papers by O. M. V. Schofield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. M. V. Schofield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. M. V. Schofield. The network helps show where O. M. V. Schofield may publish in the future.

Co-authorship network of co-authors of O. M. V. Schofield

This figure shows the co-authorship network connecting the top 25 collaborators of O. M. V. Schofield. A scholar is included among the top collaborators of O. M. V. Schofield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. M. V. Schofield. O. M. V. Schofield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schofield, O. M. V., et al.. (2013). Recommended diagnosis and management of atopic eczema. Prescriber. 24(22). 18–28. 1 indexed citations
2.
Horn, H. M., et al.. (2011). Sole Dermatitis in Children: Patch Testing Revisited. Pediatric Dermatology. 29(3). 254–257. 16 indexed citations
3.
Schofield, O. M. V., et al.. (2004). Measurement of itch using actigraphy in pediatric and adult populations. Journal of the American Academy of Dermatology. 51(6). 893–898. 58 indexed citations
4.
Schofield, O. M. V., et al.. (2004). Terbinafine-induced Subacute Cutaneous Lupus Erythematosus. Acta Dermato Venereologica. 84(6). 472–474. 16 indexed citations
5.
Iraji, Fariba & O. M. V. Schofield. (2003). A Comparative Study Of The Predisposing Factors And Natural History Of Lichen sclerosus ET Atrophicus (LSA) In Children And Adults. Indian Journal of Dermatology. 48(1). 36–38.
6.
Russell, Margaret L., et al.. (2003). The development of an objective method for measuring scratch in children with atopic dermatitis suitable for clinical use. Journal of the American Academy of Dermatology. 50(1). 33–40. 57 indexed citations
7.
Nasr, I., Andrew Tometzki, & O. M. V. Schofield. (2001). Kawasaki disease: an update. Clinical and Experimental Dermatology. 26(1). 6–12. 9 indexed citations
8.
Luqmani, Raashid, et al.. (2000). Pseudoporphyria and Nonsteroidal Antiinflammatory Agents in Children with Juvenile Idiopathic Arthritis. Pediatric Dermatology. 17(6). 480–483. 26 indexed citations
9.
Schofield, O. M. V., David A. Kist, Alfredo Lucas, et al.. (1998). Abnormal Expression of Epiligrin and α6β4 Integrin in Basal Cell Carcinoma. Dermatologic Surgery. 24(5). 555–559. 7 indexed citations
10.
McGrath, John A., O. M. V. Schofield, Phillip H. McKee, & Robin A.J. Eady. (1994). Squamous cell carcinomas in dystrophic epidermolysis bullosa. Journal of Investigative Dermatology. 103(6). 851. 3 indexed citations
11.
McGrath, John A., O. M. V. Schofield, & Robin A.J. Eady. (1994). Epidermolysis bullosa pruriginosa: dystrophic epidermolysis bullosa with distinctive clinicopathological features. British Journal of Dermatology. 130(5). 617–625. 97 indexed citations
12.
McGrath, John A., O. M. V. Schofield, Akemi Ishida‐Yamamoto, et al.. (1993). Cultured keratinocyte allografts and wound healing in severe recessive dystrophic epidermolysis bullosa. Journal of the American Academy of Dermatology. 29(3). 407–419. 33 indexed citations
13.
Verrando, Patrick, O. M. V. Schofield, Akemi Ishida‐Yamamoto, et al.. (1993). Nicein (BM-600) in Junctional Epidermolysis Bullosa: Polyclonal Antibodies Provide New Clues for Pathogenic Role. Journal of Investigative Dermatology. 101(5). 738–743. 35 indexed citations
14.
McGrath, John A., Akemi Ishida‐Yamamoto, Michael J. Tidman, et al.. (1992). Epidermolysis bullosa simplex (Dowling-Meara). A clinicopathological review. British Journal of Dermatology. 126(5). 421–430. 46 indexed citations
15.
McGrath, John A., O. M. V. Schofield, B.J. Mayou, Phillip H. McKee, & Robin A.J. Eady. (1992). Epidermolysis bullosa complicated by squamous cell carcinoma: report of 10 cases. Journal of Cutaneous Pathology. 19(2). 116–123. 81 indexed citations
16.
Schofield, O. M. V., et al.. (1990). GB3 monoclonal antibody for the diagnosis of junctional epidermolysis bullosa: Results of a multicenter study. Journal of the American Academy of Dermatology. 23(6). 1078–1083. 64 indexed citations
17.
Schofield, O. M. V., et al.. (1990). Common antigen expression between human periderm and other tissues identified by GB1-monoclonal antibody. Archives of Dermatological Research. 282(3). 143–148. 7 indexed citations
18.
McDonnell, Peter J., O. M. V. Schofield, D J Spalton, B.J. Mayou, & Robin A.J. Eady. (1989). The eye in dystrophic epidermolysis bullosa: Clinical and immunopathological findings. Eye. 3(1). 79–83. 14 indexed citations
19.
NORRIS, P.G., O. M. V. Schofield, & R.D.R. Camp. (1988). A study of the role of house dust mite in atopic dermatitis. British Journal of Dermatology. 118(3). 435–440. 95 indexed citations
20.
Schofield, O. M. V., et al.. (1983). Allergy to aminophylline.. BMJ. 286(6383). 2051–2052. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T Kobayasi Breakdown of academic impact, for papers by Fabienne Jaunin Breakdown of academic impact, for papers by Jean‐Louis Bonafé Breakdown of academic impact, for papers by Anna E. Martinez Breakdown of academic impact, for papers by Leila Youssefian Breakdown of academic impact, for papers by Richard M. Haber Breakdown of academic impact, for papers by Elżbieta Kowalska-Olędzka Breakdown of academic impact, for papers by Vesarat Wessagowit Breakdown of academic impact, for papers by Joanna Czuwara Breakdown of academic impact, for papers by Andrew P. South
Rankless by CCL
2026